Adverum Working Capital vs Free Cash Flow Analysis

ADVM Stock

USD 11.15 0.20 1.76%

Adverum Biotechnologies financial indicator trend analysis is way more than just evaluating Adverum Biotechnologies prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Adverum Biotechnologies is a good investment. Please check the relationship between Adverum Biotechnologies Working Capital and its Free Cash Flow accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Adverum Biotechnologies. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real.

To learn how to invest in Adverum Stock, please use our How to Invest in Adverum Biotechnologies guide.

Working Capital vs Free Cash Flow

Working Capital vs Free Cash Flow Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Adverum Biotechnologies Working Capital account and Free Cash Flow. At this time, the significance of the direction appears to have no relationship.

The correlation between Adverum Biotechnologies' Working Capital and Free Cash Flow is 0.0. Overlapping area represents the amount of variation of Working Capital that can explain the historical movement of Free Cash Flow in the same time period over historical financial statements of Adverum Biotechnologies, assuming nothing else is changed. The correlation between historical values of Adverum Biotechnologies' Working Capital and Free Cash Flow is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Working Capital of Adverum Biotechnologies are associated (or correlated) with its Free Cash Flow. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Free Cash Flow has no effect on the direction of Working Capital i.e., Adverum Biotechnologies' Working Capital and Free Cash Flow go up and down completely randomly.

Correlation Coefficient

0.0

Relationship Direction	Flat
Relationship Strength	Insignificant

View All Relationships

Working Capital

The difference between a company’s current assets and current liabilities, indicating the liquidity and operational efficiency of the business.

Free Cash Flow

The amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.

Most indicators from Adverum Biotechnologies' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Adverum Biotechnologies current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Adverum Biotechnologies. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real.

To learn how to invest in Adverum Stock, please use our How to Invest in Adverum Biotechnologies guide.As of the 19th of April 2024, Sales General And Administrative To Revenue is likely to grow to 17.94, while Selling General Administrative is likely to drop about 31.8 M.

	2021	2022	2023	2024 (projected)
Total Operating Expenses	153.6M	157.1M	121.7M	81.4M
Cost Of Revenue	4.6M	6.5M	5.6M	5.4M

Total Operating Expenses Cost Of Revenue

Adverum Biotechnologies fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Long Term Debt	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Property Plant Equipment	Non Currrent Assets Other	Other Assets	Net Tangible Assets
Total Assets		0.63	0.26	0.74	0.94	0.18	0.65	-0.06	-0.61	0.56	0.35	0.66	-0.52	0.94	0.46	-0.19	0.6	0.64	0.82	0.65	0.61	0.94	0.31	0.12	0.43	0.84
Short Long Term Debt Total	0.63		0.68	0.84	0.38	-0.05	0.89	0.32	-0.83	0.35	0.07	0.9	-0.53	0.39	0.5	-0.33	0.93	0.6	0.8	0.93	0.92	0.41	0.71	0.58	0.84	0.33
Other Current Liab	0.26	0.68		0.69	-0.02	-0.3	0.57	0.29	-0.82	0.35	0.02	0.57	-0.23	0.01	-0.15	-0.12	0.67	0.44	0.61	0.62	0.68	0.02	0.89	0.94	0.84	0.06
Total Current Liabilities	0.74	0.84	0.69		0.55	-0.12	0.88	0.3	-0.89	0.72	0.06	0.89	-0.43	0.55	0.22	-0.41	0.84	0.83	0.95	0.91	0.84	0.56	0.72	0.5	0.76	0.47
Total Stockholder Equity	0.94	0.38	-0.02	0.55		0.32	0.42	-0.27	-0.33	0.48	0.46	0.42	-0.47	1.0	0.4	-0.03	0.31	0.49	0.66	0.42	0.33	1.0	-0.01	-0.13	0.11	0.82
Other Liab	0.18	-0.05	-0.3	-0.12	0.32		-0.31	-0.76	0.23	-0.13	0.74	-0.28	-0.23	0.35	0.04	0.45	-0.25	-0.18	-0.1	-0.21	-0.3	0.34	-0.28	-0.18	-0.32	-0.03
Property Plant And Equipment Net	0.65	0.89	0.57	0.88	0.42	-0.31		0.55	-0.8	0.47	-0.18	1.0	-0.34	0.41	0.54	-0.58	0.95	0.7	0.84	0.99	0.96	0.42	0.64	0.39	0.79	0.43
Net Debt	-0.06	0.32	0.29	0.3	-0.27	-0.76	0.55		-0.4	0.15	-0.91	0.54	0.31	-0.3	0.21	-0.58	0.54	0.24	0.25	0.48	0.56	-0.28	0.41	0.17	0.49	0.03
Retained Earnings	-0.61	-0.83	-0.82	-0.89	-0.33	0.23	-0.8	-0.4		-0.57	0.03	-0.81	0.34	-0.34	-0.2	0.36	-0.88	-0.73	-0.89	-0.84	-0.88	-0.36	-0.91	-0.68	-0.94	-0.46
Accounts Payable	0.56	0.35	0.35	0.72	0.48	-0.13	0.47	0.15	-0.57		0.03	0.47	-0.32	0.48	-0.08	-0.28	0.38	0.9	0.65	0.47	0.36	0.49	0.37	0.12	0.34	0.36
Cash	0.35	0.07	0.02	0.06	0.46	0.74	-0.18	-0.91	0.03	0.03		-0.17	-0.53	0.49	-0.03	0.42	-0.14	0.03	0.1	-0.1	-0.17	0.48	-0.08	0.09	-0.12	0.15
Non Current Assets Total	0.66	0.9	0.57	0.89	0.42	-0.28	1.0	0.54	-0.81	0.47	-0.17		-0.34	0.41	0.54	-0.56	0.96	0.7	0.85	0.99	0.96	0.43	0.65	0.4	0.79	0.43
Long Term Debt	-0.52	-0.53	-0.23	-0.43	-0.47	-0.23	-0.34	0.31	0.34	-0.32	-0.53	-0.34		-0.48	-0.2	0.23	-0.34	-0.37	-0.4	-0.37	-0.32	-0.48	-0.27	-0.21	-0.31	-0.35
Cash And Short Term Investments	0.94	0.39	0.01	0.55	1.0	0.35	0.41	-0.3	-0.34	0.48	0.49	0.41	-0.48		0.38	-0.01	0.31	0.48	0.66	0.41	0.33	1.0	0.01	-0.1	0.12	0.82
Net Receivables	0.46	0.5	-0.15	0.22	0.4	0.04	0.54	0.21	-0.2	-0.08	-0.03	0.54	-0.2	0.38		-0.19	0.52	0.25	0.33	0.51	0.5	0.39	-0.05	-0.16	0.27	0.37
Common Stock Shares Outstanding	-0.19	-0.33	-0.12	-0.41	-0.03	0.45	-0.58	-0.58	0.36	-0.28	0.42	-0.56	0.23	-0.01	-0.19		-0.53	-0.35	-0.3	-0.52	-0.53	-0.02	-0.43	0.07	-0.41	-0.25
Non Current Liabilities Total	0.6	0.93	0.67	0.84	0.31	-0.25	0.95	0.54	-0.88	0.38	-0.14	0.96	-0.34	0.31	0.52	-0.53		0.63	0.8	0.96	0.99	0.32	0.78	0.53	0.91	0.39
Other Current Assets	0.64	0.6	0.44	0.83	0.49	-0.18	0.7	0.24	-0.73	0.9	0.03	0.7	-0.37	0.48	0.25	-0.35	0.63		0.8	0.7	0.6	0.5	0.5	0.23	0.57	0.38
Other Stockholder Equity	0.82	0.8	0.61	0.95	0.66	-0.1	0.84	0.25	-0.89	0.65	0.1	0.85	-0.4	0.66	0.33	-0.3	0.8	0.8		0.87	0.81	0.67	0.66	0.43	0.73	0.65
Total Liab	0.65	0.93	0.62	0.91	0.42	-0.21	0.99	0.48	-0.84	0.47	-0.1	0.99	-0.37	0.41	0.51	-0.52	0.96	0.7	0.87		0.96	0.43	0.69	0.47	0.82	0.4
Property Plant And Equipment Gross	0.61	0.92	0.68	0.84	0.33	-0.3	0.96	0.56	-0.88	0.36	-0.17	0.96	-0.32	0.33	0.5	-0.53	0.99	0.6	0.81	0.96		0.34	0.78	0.54	0.9	0.43
Total Current Assets	0.94	0.41	0.02	0.56	1.0	0.34	0.42	-0.28	-0.36	0.49	0.48	0.43	-0.48	1.0	0.39	-0.02	0.32	0.5	0.67	0.43	0.34		0.03	-0.09	0.13	0.82
Property Plant Equipment	0.31	0.71	0.89	0.72	-0.01	-0.28	0.64	0.41	-0.91	0.37	-0.08	0.65	-0.27	0.01	-0.05	-0.43	0.78	0.5	0.66	0.69	0.78	0.03		0.78	0.94	0.2
Non Currrent Assets Other	0.12	0.58	0.94	0.5	-0.13	-0.18	0.39	0.17	-0.68	0.12	0.09	0.4	-0.21	-0.1	-0.16	0.07	0.53	0.23	0.43	0.47	0.54	-0.09	0.78		0.77	-0.08
Other Assets	0.43	0.84	0.84	0.76	0.11	-0.32	0.79	0.49	-0.94	0.34	-0.12	0.79	-0.31	0.12	0.27	-0.41	0.91	0.57	0.73	0.82	0.9	0.13	0.94	0.77		0.29
Net Tangible Assets	0.84	0.33	0.06	0.47	0.82	-0.03	0.43	0.03	-0.46	0.36	0.15	0.43	-0.35	0.82	0.37	-0.25	0.39	0.38	0.65	0.4	0.43	0.82	0.2	-0.08	0.29

Click cells to compare fundamentals

Adverum Biotechnologies Account Relationship Matchups

Adverum Biotechnologies fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	222.7M	482.6M	439.7M	308.4M	173.0M	247.9M
Other Current Liab	2.6M	1.3M	2.0M	16.8M	12.5M	13.1M
Total Current Liabilities	19.4M	20.9M	21.3M	32.2M	24.9M	15.0M
Total Stockholder Equity	175.0M	434.3M	316.2M	181.5M	83.5M	79.3M
Other Liab	1.4M	48K	1.1M	1.0M	942.3K	895.2K
Property Plant And Equipment Net	45.8M	47.1M	119.1M	113.9M	67.0M	37.4M
Net Debt	(33.6M)	(31.7M)	68.8M	38.4M	36K	37.8K
Retained Earnings	(385.0M)	(502.5M)	(648.1M)	(802.6M)	(919.8M)	(873.8M)
Accounts Payable	4.1M	2.8M	1.4M	2.2M	1.9M	1.9M
Cash	65.9M	62.4M	34.2M	68.4M	75M	78.2M
Non Current Assets Total	46.9M	48.1M	122.6M	117.8M	70.2M	39.7M
Cash And Short Term Investments	166.0M	429.7M	305.2M	185.6M	96.5M	91.7M
Common Stock Shares Outstanding	6.4M	8.5M	9.8M	9.9M	10.1M	18.4M
Liabilities And Stockholders Equity	222.7M	482.6M	439.7M	308.4M	173.0M	247.9M
Non Current Liabilities Total	28.4M	27.3M	102.2M	94.6M	64.6M	67.9M
Other Current Assets	9.8M	4.7M	6.2M	5.0M	6.2M	4.0M
Other Stockholder Equity	560.7M	937.1M	965.0M	985.7M	1.0B	567.3M
Total Liab	47.8M	48.2M	123.5M	126.9M	89.5M	46.9M
Property Plant And Equipment Gross	24.9M	47.1M	132.2M	130.9M	81.5M	85.6M
Total Current Assets	175.9M	434.4M	317.1M	190.6M	102.8M	97.6M
Accumulated Other Comprehensive Income	(725K)	(261K)	(714K)	(1.5M)	(473K)	(496.7K)
Property Plant Equipment	24.9M	27.7M	33.1M	113.9M	130.9M	137.5M
Non Currrent Assets Other	11K	29K	250K	1.4M	1.2M	1.3M
Other Assets	1.0M	1.0M	3.5M	3.9M	4.5M	4.7M
Net Tangible Assets	175.0M	434.3M	316.2M	181.5M	208.7M	256.7M
Common Stock Total Equity	5K	6K	7K	10K	11.5K	6.5K
Retained Earnings Total Equity	(320.5M)	(385.0M)	(502.5M)	(648.1M)	(583.3M)	(554.1M)
Short Term Investments	100.1M	367.3M	271.0M	117.2M	21.5M	20.4M
Capital Surpluse	522.5M	560.7M	937.1M	965.0M	1.1B	599.6M
Short Term Debt	4.0M	4.5M	1.9M	13.2M	10.4M	6.1M
Common Stock	5K	6K	7K	10K	11.5K	7.4K
Non Current Liabilities Other	28.4M	27.3M	102.2M	1.0M	1.2M	1.1M
Net Invested Capital	175.0M	434.3M	316.2M	181.5M	83.5M	79.3M
Net Working Capital	156.5M	413.6M	295.8M	158.3M	77.9M	74.0M

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Adverum Biotechnologies in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Adverum Biotechnologies' short interest history, or implied volatility extrapolated from Adverum Biotechnologies options trading.

Pair Trading with Adverum Biotechnologies

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Adverum Biotechnologies position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Adverum Biotechnologies will appreciate offsetting losses from the drop in the long position's value.

Moving together with Adverum Stock

0.66

EOLS

Evolus Inc Financial Report 14th of May 2024

Pair Corr

Moving against Adverum Stock

0.47

MRKR

Marker Therapeutics

Pair Corr

The ability to find closely correlated positions to Adverum Biotechnologies could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Adverum Biotechnologies when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Adverum Biotechnologies - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Adverum Biotechnologies to buy it.

The correlation of Adverum Biotechnologies is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Adverum Biotechnologies moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Adverum Biotechnologies moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Adverum Biotechnologies can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Adverum Biotechnologies is a strong investment it is important to analyze Adverum Biotechnologies' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Adverum Biotechnologies' future performance. For an informed investment choice regarding Adverum Stock, refer to the following important reports:

How To Invest In Adverum

Details

Is Adverum Stock a good investment?

Details

What is Adverum Biotechnologies' Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Adverum Biotechnologies. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real.

To learn how to invest in Adverum Stock, please use our How to Invest in Adverum Biotechnologies guide.

You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.

Complementary Tools for Adverum Stock analysis

When running Adverum Biotechnologies' price analysis, check to measure Adverum Biotechnologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Adverum Biotechnologies is operating at the current time. Most of Adverum Biotechnologies' value examination focuses on studying past and present price action to predict the probability of Adverum Biotechnologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Adverum Biotechnologies' price. Additionally, you may evaluate how the addition of Adverum Biotechnologies to your portfolios can decrease your overall portfolio volatility.

	Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
	Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments
	Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
	Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
	Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk
	USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA
	My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
	Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon
	Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format

Is Adverum Biotechnologies' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Adverum Biotechnologies. If investors know Adverum will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Adverum Biotechnologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(11.60)

Revenue Per Share

0.357

Quarterly Revenue Growth

(0.70)

Return On Assets

(0.32)

Return On Equity

(0.88)

The market value of Adverum Biotechnologies is measured differently than its book value, which is the value of Adverum that is recorded on the company's balance sheet. Investors also form their own opinion of Adverum Biotechnologies' value that differs from its market value or its book value, called intrinsic value, which is Adverum Biotechnologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Adverum Biotechnologies' market value can be influenced by many factors that don't directly affect Adverum Biotechnologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Adverum Biotechnologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Adverum Biotechnologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Adverum Biotechnologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Adverum Working Capital vs Free Cash Flow Analysis

Working Capital vs Free Cash Flow

Working Capital vs Free Cash Flow Correlation Analysis

Correlation Coefficient

Working Capital

Free Cash Flow

Adverum Biotechnologies fundamental ratios Correlations

Adverum Biotechnologies Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Adverum Biotechnologies fundamental ratios Accounts

Pair Trading with Adverum Biotechnologies

Moving together with Adverum Stock

Moving against Adverum Stock

Complementary Tools for Adverum Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Total Stockholder Equity
Total Current Assets	+ 1.0	Total Stockholder Equity
Non Current Assets Total	+ 1.0	Property Plant And Equipment Net
Total Current Assets	+ 1.0	Cash And Short Term Investments
Total Liab	+ 0.99	Property Plant And Equipment Net
Total Liab	+ 0.99	Non Current Assets Total

Other Assets	- 0.94	Retained Earnings
Property Plant Equipment	- 0.91	Retained Earnings
Cash	- 0.91	Net Debt
Other Stockholder Equity	- 0.89	Retained Earnings
Retained Earnings	- 0.89	Total Current Liabilities
Property Plant And Equipment Gross	- 0.88	Retained Earnings